AAAAAA
Results:
1-25
|
Results: 25
Authors:
Bilezikjian, LM
Blount, AL
Corrigan, AZ
Leal, A
Chen, Y
Vale, WW
Citation: Lm. Bilezikjian et al., Actions of activins, inhibins and follistatins: Implications in anterior pituitary function, CLIN EXP PH, 28(3), 2001, pp. 244-248
Authors:
Reyes, TM
Lewis, K
Perrin, MH
Kunitake, KS
Vaughan, J
Arias, CA
Hogenesch, JB
Gulyas, J
Rivier, J
Vale, WW
Sawchenko, PE
Citation: Tm. Reyes et al., Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors, P NAS US, 98(5), 2001, pp. 2843-2848
Authors:
Lewis, K
Li, C
Perrin, MH
Blount, A
Kunitake, K
Donaldson, C
Vaughan, J
Reyes, TM
Gulyas, J
Fischer, W
Bilezikjian, L
Rivier, J
Sawchenko, PE
Vale, WW
Citation: K. Lewis et al., Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor, P NAS US, 98(13), 2001, pp. 7570-7575
Authors:
Perrin, MH
Fischer, WH
Kunitake, KS
Craig, AG
Koerber, SC
Cervini, LA
Rivier, JE
Groppe, JC
Greenwald, J
Nielsen, SM
Vale, WW
Citation: Mh. Perrin et al., Expression, purification, and characterization of a soluble form of the first extracellular domain of the human type 1 corticotropin releasing factorreceptor, J BIOL CHEM, 276(34), 2001, pp. 31528-31534
Authors:
Bilezikjian, LM
Corrigan, AZ
Blount, AL
Chen, Y
Vale, WW
Citation: Lm. Bilezikjian et al., Regulation and actions of Smad7 in the modulation of activin, inhibin, andtransforming growth factor-beta signaling in anterior pituitary cells, ENDOCRINOL, 142(3), 2001, pp. 1065-1072
Authors:
Sutton, SW
Akhtar, M
Schmidt, K
Fischer, WH
Vale, WW
Craig, AG
Citation: Sw. Sutton et al., Characterization of the N-linked glycan of recombinantly-expressed corticotropin releasing factor binding protein, EUR J MASS, 6(4), 2000, pp. 335-346
Authors:
Bale, TL
Contarino, AB
Smith, GW
Chan, R
Gold, LH
Sawchenko, PE
Koob, GF
Vale, WW
Lee, KF
Citation: Tl. Bale et al., Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress, NAT GENET, 24(4), 2000, pp. 410-414
Authors:
Chan, RKW
Vale, WW
Sawchenko, PE
Citation: Rkw. Chan et al., Paradoxical activational effects of a corticotropin-releasing factor-binding protein "ligand inhibitor" in rat brain, NEUROSCIENC, 101(1), 2000, pp. 115-129
Authors:
Nielsen, SM
Nielsen, LZ
Hjorth, SA
Perrin, MH
Vale, WW
Citation: Sm. Nielsen et al., Constitutive activation of tethered-peptide/corticotropin-releasing factorreceptor chimeras, P NAS US, 97(18), 2000, pp. 10277-10281
Authors:
Bradbury, MJ
McBurnie, MI
Denton, DA
Lee, KF
Vale, WW
Citation: Mj. Bradbury et al., Modulation of urocortin-induced hypophagia and weight loss by corticotropin-releasing factor receptor 1 deficiency in mice, ENDOCRINOL, 141(8), 2000, pp. 2715-2724
Authors:
Kageyama, K
Gaudriault, GE
Bradbury, MJ
Vale, WW
Citation: K. Kageyama et al., Regulation of corticotropin-releasing factor receptor type 2 beta messenger ribonucleic acid in the rat cardiovascular system by urocortin, glucocorticoids, and cytokines, ENDOCRINOL, 141(7), 2000, pp. 2285-2293
Authors:
Contarino, A
Dellu, F
Koob, GF
Smith, GW
Lee, KF
Vale, WW
Gold, LH
Citation: A. Contarino et al., Dissociation of locomotor activation and suppression of food intake induced by CRF in CRFR1-deficient mice, ENDOCRINOL, 141(7), 2000, pp. 2698-2702
Authors:
Greenwald, J
Fischer, WH
Vale, WW
Choe, S
Citation: J. Greenwald et al., Three-finger toxin fold for the extracellular ligand-binding domain of thetype II activin receptor serine kinase., NAT ST BIOL, 6(1), 1999, pp. 18-22
Authors:
Aubry, JM
Pozzoli, G
Vale, WW
Citation: Jm. Aubry et al., Chronic treatment with the antidepressant amitriptyline decreases CRF-R1 receptor mRNA levels in the rat amygdala, NEUROSCI L, 266(3), 1999, pp. 197-200
Authors:
Cepoi, D
Sutton, S
Arias, C
Sawchenko, P
Vale, WW
Citation: D. Cepoi et al., Ovine genomic urocortin: cloning, pharmacologic characterization, and distribution of central mRNA, MOL BRAIN R, 68(1-2), 1999, pp. 109-118
Authors:
Perrin, MH
Sutton, SW
Cervini, LA
Rivier, JE
Vale, WW
Citation: Mh. Perrin et al., Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors, J PHARM EXP, 288(2), 1999, pp. 729-734
Authors:
Rivier, JE
Kirby, DA
Lahrichi, SL
Corrigan, A
Vale, WW
Rivier, CL
Citation: Je. Rivier et al., Constrained corticotropin releasing factor antagonists (astressin analogues) with long duration of action in the rat, J MED CHEM, 42(16), 1999, pp. 3175-3182
Authors:
Bittencourt, JC
Vaughan, J
Arias, C
Rissman, RA
Vale, WW
Sawchenko, PE
Citation: Jc. Bittencourt et al., Urocortin expression in rat brain: Evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors, J COMP NEUR, 415(3), 1999, pp. 285-312
Authors:
Peto, CA
Arias, C
Vale, WW
Sawchenko, PE
Citation: Ca. Peto et al., Ultrastructural localization of the corticotropin-releasing factor-bindingprotein in rat brain and pituitary, J COMP NEUR, 413(2), 1999, pp. 241-254
Authors:
Takabe, K
Lebrun, JJ
Nagashima, Y
Ichikawa, Y
Mitsuhashi, M
Momiyama, N
Ishikawa, T
Shimada, H
Vale, WW
Citation: K. Takabe et al., Interruption of activin A autocrine regulation by antisense oligodeoxynucleotides accelerates liver tumor cell proliferation, ENDOCRINOL, 140(7), 1999, pp. 3125-3132
Authors:
Donaldson, CJ
Vaughan, JM
Corrigan, AZ
Fischer, WH
Vale, WW
Citation: Cj. Donaldson et al., Activin and inhibin binding to the soluble extracellular domain of activinreceptor II, ENDOCRINOL, 140(4), 1999, pp. 1760-1766
Authors:
Turnbull, AV
Smith, GW
Lee, S
Vale, WW
Lee, KF
Rivier, C
Citation: Av. Turnbull et al., CRF type I receptor-deficient mice exhibit a pronounced pituitary-adrenal response to local inflammation, ENDOCRINOL, 140(2), 1999, pp. 1013-1017
Authors:
Kageyama, K
Bradbury, MJ
Zhao, LY
Blount, AL
Vale, WW
Citation: K. Kageyama et al., Urocortin messenger ribonucleic acid: Tissue distribution in the rat and regulation in thymus by lipopolysaccharide and glucocorticoids, ENDOCRINOL, 140(12), 1999, pp. 5651-5658
Authors:
Turnbull, AV
Vaughan, J
Rivier, JE
Vale, WW
Rivier, C
Citation: Av. Turnbull et al., Urocortin is not a significant regulator of intermittent electrofootshock-induced adrenocorticotropin secretion in the intact male rat, ENDOCRINOL, 140(1), 1999, pp. 71-78
Authors:
Lovejoy, DA
Hewett-Emmett, D
Porter, CA
Cepoi, D
Sheffield, A
Vale, WW
Tashian, RE
Citation: Da. Lovejoy et al., Evolutionarily conserved, "acatalytic" carbonic anhydrase-related protein XI contains a sequence motif present in the neuropeptide sauvagine: The human CA-RP XI gene (CA11) is embedded between the secretor gene cluster and the DBP gene at 19q13.3, GENOMICS, 54(3), 1998, pp. 484-493
Risultati:
1-25
|